$CLNeutralLow

Is Colgate-Palmolive Stock Underperforming the Dow?

Colgate-Palmolive (CL) is down about 11.1% from its Feb. 27 52-week high of $99.33 and has fallen 9.3% over three months versus the Dow’s 4.9% gain, though it is up 11.7% YTD versus the index’s 6.8%. After its May 1 Q1 2026 report, revenue rose 8.4% to $5.3B and adjusted EPS rose to $0.97. Analysts rate it “Moderate Buy” with a $95.16 mean target.

6/10
4/10
Low
Neutral
post-market recap of relative performance and prior Q1 beat
moderately supportive (analyst Moderate Buy; mean target implies upside) but framed as underperforming

CL is positioned as a relative laggard despite a recent earnings beat and technical strength above key moving averages.

Article frames Colgate-Palmolive’s relative underperformance versus the Dow while citing its better-than-expected Q1 2026 results and moving-average trend.

Near-term trading likely hinges on whether investors re-rate CL versus the Dow; absent new guidance, impact should be modest.

Background

The article compares CL’s recent and longer-term performance versus the Dow and notes a May 1 earnings beat (Q1 2026) with revenue and adjusted EPS above expectations.

Why it matters

Relative underperformance could attract mean-reversion or defensive re-rating trades, but the lack of new company-specific developments limits immediate repricing catalysts.

Market relevance

Traders get a relative-performance and technical snapshot for CL, anchored to previously reported Q1 results and a consensus target range.

Market effects

Consumer staples relative-performance narrative may influence factor flows between defensives and broader benchmarks.

US-focused read-through via Dow-relative comparison; limited direct regional spillover described.

CL’s global revenue mix is referenced, but no new macro/geographic catalyst is introduced.

Alternative perspectives

The “underperforming the Dow” framing may be misleading because CL is still up YTD and trading above 50/200-day averages, suggesting the lag is more about benchmark strength than CL deterioration.

The article doesn’t quantify valuation, margin trajectory, or forward demand; without those, relative-performance conclusions may not translate into actionable near-term direction.

Key entities

  • Colgate-Palmolive Company

    Subject of the article; discussed in terms of relative stock performance, technical trend, and prior Q1 2026 earnings beat.

  • Kimberly-Clark Corporation

    Used as a peer comparison for 52-week and YTD performance; no separate news catalyst described.

Related articles

$KOMed

Stocks Tumble Earthward by Noon

Canada’s TSX Composite fell 1.5% to 34,680.83 by noon Friday, tracking Wall Street declines after stronger-than-expected U.S. and Canadian payroll data raised expectations of tighter policy. Statistics Canada reported 88,000 jobs added in May and unemployment down to 6.6%. TSX Venture slid 4.6%. On Wall Street, S&P 500 and Nasdaq dropped as Treasury yields rose to 4.54% and chip stocks sold off.

$CLLow

Colgate Optic White® x Chicha San Chen Proudly Debut the "Dental-Grade Teeth Whitening Lab"

Colgate Optic White® and Taiwan tea chain Chicha San Chen launched a crossover promotion in Hong Kong, running June 5–July 4, 2026. All 17 Chicha San Chen branches will sell the limited drink “Optic White Green Tea with Mist Foam” (HK$43). The brands cite Colgate’s 5% hydrogen peroxide (HP) whitening toothpaste and offer 500 complimentary drinks and toothpaste vouchers, plus a June 19–25 pop-up at five locations.

$KOLow

Mood chocolate, nootropic whiskey and ten-cent toothpaste: what the K-shaped economy means for your shopping basket

RBC Capital Markets said in a research note that the “K-shaped economy” is structural, not cyclical, and will intensify through the decade, pushing consumer goods firms toward “barbell” portfolios with growth at the extremes and little in the middle. It cited widening gaps in AI access, wealth, healthspan, and education. RBC analyst Nik Modi warned Amazon and Temu could disintermediate brands.

$CLLow

Colgate-Palmolive India raises ad Spend 10.5% to Rs 199 crore in Q4 FY26

Colgate-Palmolive India increased its advertising and promotional spending by 10.5% year-on-year to Rs 199 crore in Q4 FY26, despite a marginal decline in quarterly profit. The company's total expenses rose to Rs 1,121.6 crore, primarily due to higher investments in marketing and operations. For the full fiscal year FY26, ad spend reached Rs 819 crore, and total income grew by 8.8% to Rs 1,612.2 crore.

$CLLow

Colgate-Palmolive India Q4 profit flat amid GST-related charge impact

Colgate-Palmolive India reported largely flat net profit for the quarter ended March, primarily due to GST-related charges, income-tax refund credit adjustments, and organizational restructuring costs. Despite these impacts, the company's revenue increased by 9.1% year-on-year to Rs 1,595.4 crore, driven by broad-based growth across its core and premium portfolios. The company emphasized its focus on premiumisation and disciplined cost management to sustain growth momentum.

$CLMed

Colgate India spends nearly Rs 200 crore on advertising in Q4 as sales growth accelerates

Colgate-Palmolive India increased its Q4 FY26 advertising and promotional spending by 10.5% to nearly Rs 200 crore despite a slight decline in quarterly net profit to Rs 353.3 crore. The company saw strong topline growth, with total income rising 8.8% year-on-year, driven by broad-based growth in both core and premium products. This increased investment in advertising and premium initiatives reflects the company's strategy to accelerate sales growth amidst intensified competition in the FMCG sector.